Africa Muxí
Nuclear Medicine Department
Hospital Clínic
Universitat de Barcelona
Barcelona
Spain
Name/email consistency: high
- Diagnostic cutoff points for (123)I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease. Muxí, A., Paredes, P., Navales, I., Valldeoriola, F., Gaig, C., Lomeña, F., de la Cerda, A., Solà, O., Domenech, B., Tolosa, E., Pons, F. Eur. J. Nucl. Med. Mol. Imaging (2011)
- Arteriovenous fistula affects bone mineral density measurements in end-stage renal failure patients. Muxí, A., Torregrosa, J.V., Fuster, D., Peris, P., Vidal-Sicart, S., Solá, O., Domenech, B., Martín, G., Casellas, J., Pons, F. Clin. J. Am. Soc. Nephrol (2009)
- Left ventricular function and visual phase analysis with equilibrium radionuclide angiography in patients with biventricular device. Muxí, A., Paredes, P., Mont, L., Setoain, F.J., Duch, J., Fuertes, S., Ortín, J., Diaz-Infante, E., Pons, F. Eur. J. Nucl. Med. Mol. Imaging (2008)
- Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization. Muxí, A., Magriñá, J., Martín, F., Josa, M., Fuster, D., Setoain, F.J., Pérez-Villa, F., Pavía, J., Bosch, X. J. Thorac. Cardiovasc. Surg. (2003)